AYTU Biolidics launches rapid test kit for COVID-19 https://www.biospectrumasia.com/news/26/15878/biolidics-launches-rapid-test-kit-for-covid-19-.html
Aytu BioScience, Inc. (AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced today that the Company will present its operational results for the quarter ended March 31, 2020 on May 14, 2020, at 4:30 p.m. ET. The Company will review accomplishments from the quarter and provide an overview of its business and growth strategy. Conference Call Information">Conference Call Information 1- 201-689-8584 (international)">1- 877-407-9124 (toll-free) 1- 201-689-8584 (international) aytubio.com, for 90 days.">The webcast will be accessible live and archived on Aytu BioScience's website, within the Investors section under Events & Presentations, at aytubio.com, for 90 days. A replay of the call will be available for fourteen days. Access the replay by calling 1-877-481-4010 (toll-free) or 919-882-2331 (international) and using the replay access code 34718.
AYTU BioScience Announces $15 Million Debt Retirement Company Retires $15M Obligation Assumed with Previously Announced Cerecor Commercial Portfolio Asset Purchase">Company Retires $15M Obligation Assumed with Previously Announced Cerecor Commercial Portfolio Asset Purchase Company's Debt Reduced to Approximately $1 Million">Company's Debt Reduced to Approximately $1 Million https://finance.yahoo.com/news/aytu-bioscience-announces-15-million-200100609.html
AYTU BioScience Announces Emergency Use Authorization of COVID-19 IgG/IgM Rapid Test Fourth FDA Emergency Use Authorization of a COVID-19 IgG/IgM Lateral Flow Rapid Test" data-reactid="12">Fourth FDA Emergency Use Authorization of a COVID-19 IgG/IgM Lateral Flow Rapid Test 1.4 Million Rapid Tests Available for Distribution at Company's Warehouse " data-reactid="13">1.4 Million Rapid Tests Available for Distribution at Company's Warehouse https://finance.yahoo.com/news/aytu-bioscience-announces-emergency-authorization-120000355.html
Aytu BioScience Announces Significant Improvement in Natesto(R) Patient Access in the United States https://finance.yahoo.com/news/aytu-bioscience-announces-significant-improvement-120000333.html
AYTU Aytu BioScience Set to Join Russell 3000(R) Index https://finance.yahoo.com/news/aytu-bioscience-set-join-russell-120000765.html
AYTU Aytu BioScience: The Next Arbor Pharmaceuticals? https://seekingalpha.com/article/4354610-aytu-bioscience-next-arbor-pharmaceuticals
AYTU News! 7/10/20 Aytu BioScience Announces Distribution Partnership with Apollo Med https://finance.yahoo.com/news/aytu...ion-partnership-120000895.html?.tsrc=fin-srch
$AYTU Aytu BioScience Announces Expansion of NATESTO(R) U.S. Commercial Team https://www.accesswire.com/598017/Aytu-BioScience-Announces-Expansion-of-NATESTOR-US-Commercial-Team
